The 2-day forum held at the Geneva headquarters of the World Health Organization in accordance with the WHO R&D Blueprint agreed to accelerate research activities and set global research priorities needed to stop the COVID-19 outbreak.
The meeting, hosted in collaboration with GloPID-R (the Global Research Collaboration for Infectious Disease Preparedness) came to an end on 12th February 2020.
The WHO R&D blueprint focuses on rapid initiation of research and development activities during epidemics and to fast-track the availability of effective tests, vaccines, and drugs that can be used to save lives.
The convention discussed aspects of the COVID-19 outbreak and ways to prevent and control it, including ways to protect health care workers, and research and development for candidate therapeutics and vaccines, and ethical considerations for research.
“This meeting allowed us to identify urgent priorities for research. As a group of funders we will continue to mobilize, coordinate and align our funding to enable the research needed to tackle this crisis and stop the outbreak, in partnership with WHO,” said Professor Yazdan Yazdanpanah, chair of GloPID-R.
“Equitable access – making sure we share data and reach those most in need, in particular those in lower and middle-income countries, is fundamental to this work which must be guided by ethical considerations at all times,” he added.
More than 300 participants convened at the forum agreeing to identify gaps and work together to accelerate to help stop the outbreak and prepare for any future outbreaks.